Mental health in the workplace is the theme of World Mental Health Day 2017. World Mental Health Day is observed on 10 October every year, with the overall objective of raising awareness of mental health issues and mobilizing efforts in support of better mental health.
The Global Burden of Disease (GBD) 2016 data released on 15th September reveals that Non-Communicable Diseases (NCDs) & Injuries continue to be the main cause of death among people of all age-group in India.
Our research on hip fracture in older adults reveals vital gaps in the management of older people with hip fractures against the recommended best practices.
Hip-fracture in older adults is one of the major public health issue in India and requires high quality of interdisciplinary care. The global burden of hip fractures is estimated to increase significantly from an around 1.7 million in 1990 to 6.3 million in 2050. These increases are primarily the consequence of improved life expectancy, especially in emerging economies.
The George Institute for Global Health, in collaboration with Chandigarh Commission for Protection of Child Rights and School of Public Health, PGIMER launched #EatLessSalt, a “Salt Literacy Campaign” in schools of Chandigarh. The campaign aims to spread awareness and sensitize school children and their families on the harmful effects of excess salt in our diet.
The round table meeting was hosted on 28th August 2017 by The George Institute for Global Health India in partnership with other organisations. It brought together key stakeholders to discuss the issues related to tribal mental health- resulting in a detailed report with key recommendations on how to address the tribal mental health issues in India.
With the aim of initiating dialogue around various aspects of women’s health, The George Institute for Global Health along with the Indian Council of Medical Research organized a round table bringing together government representatives, researchers, academics, funding agencies and institutional bodiesin New Delhi on August 10.
According to our new study published in the JAMA today, treatment with pills of the steroid methylprednisolone has been associated with an unexpectedly large increase in the risk of serious adverse events, primary infections among patients with IgA nephropathy and excess protein in their urine.